Viewing StudyNCT05906953

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 7:08 PM
Last Modification Date: 2024-10-26 @ 3:01 PM
Study NCT ID: NCT05906953
Status: RECRUITING
Last Update Posted: 2023-11-13
First Post: 2023-05-09
Brief Title: Safety and Efficacy Trial of HG004 for Leber Congenital Amaurosis Related to Rpe65 Gene Mutations STAR
Sponsor: HuidaGene Therapeutics Co Ltd
Organization: HuidaGene Therapeutics Co Ltd
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Inherited Retinal Diseases Caused by RPE65 Mutations
Leber Congenital Amaurosis
Keywords:
Name View
LCA2 View
IRD View
LCA View